Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C

BACKGROUND/AIMS: This study was performed to evaluate the efficacy of direct-acting antivirals (DAAs) in Korean patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) and to investigate the risk factors associated with HCC recurrence. METHODS: A total of 100 patients with HCV-r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gut Liver
Autors principals: Ahn, Young-Hwan, Lee, Heirim, Kim, Do Young, Lee, Hye Won, Yu, Su Jong, Cho, Young Youn, Jang, Jeong Won, Jang, Byoung Kuk, Kim, Chang Wook, Kim, Hee Yeon, Park, Hana, Cho, Hyo Jung, Park, Bumhee, Kim, Soon Sun, Cheong, Jae Youn
Format: Artigo
Idioma:Inglês
Publicat: Editorial Office of Gut and Liver 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8129654/
https://ncbi.nlm.nih.gov/pubmed/32893194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl20151
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars